Even light drinking puts women at greater risk to develop cancer


(HealthDay News) -- The risk of alcohol-related cancer is increased even with light to moderate drinking in women, according to a study published online Aug. 18 in The BMJ.

Yin Cao, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues quantified risk of overall cancer across all levels of alcohol consumption. Data were included for 88,084 women and 47,881 men participating in the Nurses' Health Study and Health Professionals Follow-up Study.

The researchers found that for women, light to moderate drinkers versus non-drinkers had relative risks of 1.02 (95 percent confidence interval [CI], 0.98 to 1.06) and 1.04 (95 percent CI, 1.00 to 1.09; Ptrend = 0.12), respectively, for alcohol intake of 0.1 to 4.9 and 5 to 14.9 g/day. For men, the relative risks were 1.03 (95 percent CI, 0.96 to 1.11), 1.05 (95 percent CI, 0.97 to 1.12), and 1.06 (95 percent CI, 0.98 to 1.15; Ptrend = 0.31) for alcohol intake of 0.1 to 4.9, 5 to 14.9, and 15 to 29.9 g/day, respectively. For men, the risk of a priori defined alcohol-related cancers was not appreciably increased for light or moderate drinkers who never smoked. Even alcohol consumption of 5 to 14.9 g/day correlated with increased risk of alcohol-related cancer for women (relative risk, 1.13), driven by breast cancer.

"Light to moderate drinking is associated with minimally increased risk of overall cancer," the authors write.

Full Text
Editorial

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs